Bic


Sales momentum decelerates in Q4 19; outlook for FY20 also weak

13/02/20 -"With four consecutive quarters of negative organic growth, Bic’s FY19 sales came in at the lower end of the target range – while lighters and stationery were under pressure throughout the year, ..."

Pages
45
Language
English
Published on
13/02/20
You may also be interested by these reports :
13/02/20
With four consecutive quarters of negative organic growth, Bic’s FY19 sales came in at the lower end of the target range – while lighters and ...

12/02/20
Reckitt Benckiser (Add, UK) needs a serious health check-up. We last teased on this UK-based health & hygiene leader in April 2019, when management’s ...

10/02/20
The group has released a very strong year-end trading performance, especially in Asia Pacific. The better than expected revenue growth (9.6% lfl vs. ...

10/02/20
We continue to have mixed feelings about the group. Although driven by large volumes, sales growth remains weak (+2.9% in FY19, +1.5% in Q4). ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO